Pherecydes Pharma Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 27

Employees

  • Latest Deal Type
  • M&A

Pherecydes Pharma General Information

Description

Pherecydes Pharma develops phage-based therapeutic solutions for the treatment of bacterial infections. It focuses on various bacterial infections, including antibiotic-resistant infections, using phages, natural predators of bacteria that have no effect on eukaryotic cells, including human cells.

Contact Information

Website
www.pherecydes-pharma.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 22 Boulevard Bénoni Goullin
  • 44200 Nantes
  • France
+33 01
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Parent Company
PHAXIAM Therapeutics
Vertical(s)
Life Sciences
Corporate Office
  • 22 Boulevard Bénoni Goullin
  • 44200 Nantes
  • France
+33 01

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Pherecydes Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Merger/Acquisition 23-Jun-2023 Completed Generating Revenue
9. PIPE 22-Sep-2022 Completed Generating Revenue
8. IPO 05-Feb-2021 Completed Generating Revenue
7. Later Stage VC 30-Oct-2019 Completed Generating Revenue
6. Grant 01-Feb-2018 Completed Generating Revenue
5. Later Stage VC (Series B) 16-Jan-2018 Completed Generating Revenue
4. Later Stage VC (Series A) 18-Mar-2015 Completed Generating Revenue
3. Grant 18-Jan-2012 Completed Generating Revenue
2. Angel (individual) 01-Jan-2007 $3.03M $3.03M Completed Generating Revenue
1. Accelerator/Incubator Completed Startup
To view Pherecydes Pharma’s complete valuation and funding history, request access »

Pherecydes Pharma Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
P1 shares
ABSA 1
P1 shares
Ordinary 23,413 $1.104264 $5.99 $5.99 1x $5.99 0.67%
P1 shares 1,190,232 $1.104264 $5.99 $5.99 1x $5.99 34.01%
To view Pherecydes Pharma’s complete cap table history, request access »

Pherecydes Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Pherecydes Pharma develops phage-based therapeutic solutions for the treatment of bacterial infections. It focuses on va
Drug Discovery
Nantes, France
27 As of 2022

Gaithersburg, MD
 

Paris, France
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Pherecydes Pharma Competitors (22)

One of Pherecydes Pharma’s 22 competitors is BiomX, a Formerly VC-backed company based in Gaithersburg, MD.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
BiomX Formerly VC-backed Gaithersburg, MD
Eligo Bioscience Venture Capital-Backed Paris, France
SynDevRx Venture Capital-Backed Cambridge, MA
Enterome Venture Capital-Backed Paris, France
Xeno Biosciences Venture Capital-Backed Cambridge, MA
You’re viewing 5 of 22 competitors. Get the full list »

Pherecydes Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pherecydes Pharma Former Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
ACE Biotech Incubator Accelerator/Incubator
Auriga Partners (Paris) Venture Capital Minority
DGA France Government
Elaia Partners Venture Capital Minority
FaDiese Venture Capital Minority
You’re viewing 5 of 12 investors. Get the full list »

Ready to get started?

Request a free trial

Pherecydes Pharma FAQs

  • When was Pherecydes Pharma founded?

    Pherecydes Pharma was founded in 2006.

  • Where is Pherecydes Pharma headquartered?

    Pherecydes Pharma is headquartered in Nantes, France.

  • What is the size of Pherecydes Pharma?

    Pherecydes Pharma has 27 total employees.

  • What industry is Pherecydes Pharma in?

    Pherecydes Pharma’s primary industry is Drug Discovery.

  • Is Pherecydes Pharma a private or public company?

    Pherecydes Pharma is a Private company.

  • What is Pherecydes Pharma’s current revenue?

    The current revenue for Pherecydes Pharma is .

  • How much funding has Pherecydes Pharma raised over time?

    Pherecydes Pharma has raised $34.3M.

  • Who are Pherecydes Pharma’s investors?

    ACE Biotech Incubator, Auriga Partners (Paris), DGA France, Elaia Partners, and FaDiese are 5 of 12 investors who have invested in Pherecydes Pharma.

  • Who are Pherecydes Pharma’s competitors?

    BiomX, Eligo Bioscience, SynDevRx, Enterome, and Xeno Biosciences are some of the 22 competitors of Pherecydes Pharma.

  • When was Pherecydes Pharma acquired?

    Pherecydes Pharma was acquired on 23-Jun-2023.

  • Who acquired Pherecydes Pharma?

    Pherecydes Pharma was acquired by PHAXIAM Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »